Earnings Scheduled For February 27, 2015

CST Brands, Inc. CST is projected to report its Q4 earnings at $0.76 per share on revenue of $2.93 billion. Rowan Companies plc RDC is expected to report its Q4 earnings at $0.89 per share on revenue of $529.90 million. Goodrich Petroleum Corp. GDP is estimated to report a Q4 loss at $0.45 per share on revenue of $58.00 million. Del Frisco's Restaurant Group, Inc. DFRG is expected to report its Q4 earnings at $0.41 per share on revenue of $108.01 million. Exelis Inc. XLS is projected to report its Q4 earnings at $0.45 per share on revenue of $912.12 million. Icahn Enterprises, L.P. IEP is expected to report its Q4 earnings at $1.76 per share on revenue of $1.79 billion. AAON Inc. AAON is estimated to report its Q4 earnings at $0.19 per share on revenue of $82.34 million. Diana Containerships Inc. DCIX is projected to report its Q4 earnings at $0.01 per share on revenue of $13.84 million. TETRA Technologies, Inc. TTI is estimated to report its Q4 earnings at $0.08 per share on revenue of $313.72 million. PNM Resources, Inc. PNM is expected to report its Q4 earnings at $0.23 per share on revenue of $337.50 million. Westmoreland Coal Co. WLB is projected to report its Q4 earnings at $0.37 per share on revenue of $314.00 million. Granite Construction Incorporated GVA is estimated to report its Q4 earnings at $0.70 per share on revenue of $713.96 million. Northwest Natural Gas Company NWN is expected to report its Q4 earnings at $1.11 per share on revenue of $268.61 million. Isis Pharmaceuticals, Inc. ISIS is projected to report its Q4 earnings at $0.02 per share on revenue of $74.58 million. A. M. Castle & Co. CAS is expected to report a Q4 loss at $0.43 per share on revenue of $228.60 million. Horizon Pharma plc HZNP is projected to report its Q4 earnings at $0.22 per share on revenue of $95.54 million. Cleco Corporation CNL is expected to post its Q4 earnings at $0.48 per share on revenue of $252.44 million. NRG Energy, Inc. NRG is estimated to report its Q4 earnings at $0.52 per share on revenue of $2.90 billion. PTC Therapeutics, Inc. PTCT is expected to report a Q4 loss at $0.82 per share on revenue of $9.24 million. OM Asset Management Limited OMAM is projected to report its Q4 earnings at $0.30 per share on revenue of $162.44 million. Keryx Biopharmaceuticals Inc. KERX is expected to report a Q4 loss at $0.37 per share on revenue of $1.23 million.